BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 6509805)

  • 1. Subentities within adult primary IgA-nephropathy.
    Beukhof JR; Ockhuizen T; Halie LM; Westra J; Beelen JM; Donker AJ; Hoedemaeker PJ; van der Hem GK
    Clin Nephrol; 1984 Oct; 22(4):195-9. PubMed ID: 6509805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and natural history of IgA nephropathy.
    Rychlik I; Andrassy K; Waldherr R; Zuna I; Tesar V; Jancová E; Stejskalová A; Ritz E
    Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
    Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.
    Lee HS; Lee MS; Lee SM; Lee SY; Lee ES; Lee EY; Park SY; Han JS; Kim S; Lee JS
    Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berger's disease in children. Natural history and outcome.
    Lévy M; Gonzalez-Burchard G; Broyer M; Dommergues JP; Foulard M; Sorez JP; Habib R
    Medicine (Baltimore); 1985 May; 64(3):157-80. PubMed ID: 3887094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic IgA mesangial nephropathy. Clinical and histological study of 374 patients.
    D'Amico G; Imbasciati E; Barbiano Di Belgioioso G; Bertoli S; Fogazzi G; Ferrario F; Fellin G; Ragni A; Colasanti G; Minetti L
    Medicine (Baltimore); 1985 Jan; 64(1):49-60. PubMed ID: 3880853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemizygous Fabry disease associated with IgA nephropathy: a case report.
    Shimohata H; Yoh K; Takada K; Tanaka H; Usui J; Hirayama K; Kobayashi M; Yamagata K
    J Nephrol; 2009; 22(5):682-4. PubMed ID: 19810002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions.
    Jiang L; Zhang JJ; Lv JC; Liu G; Zou WZ; Zhao MH; Zhang H
    Nephrol Dial Transplant; 2008 Dec; 23(12):3921-7. PubMed ID: 18603547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative study of mesangial deposits and glomerular monocytes/macrophages in IgA-nephropathy and proliferative mesangial (non-IgA) glomerulonephritis.
    Danilewicz M; Wagrowska-Danilewicz M
    J Nephrol; 1998; 11(5):255-60. PubMed ID: 9831239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum IgA-fibronectin complex in children with various renal diseases].
    Sakai Y; Inaba S; Matsukura H; Okada T
    Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1130-6. PubMed ID: 7815745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesangial IgA nephropathy and idiopathic nephrotic syndrome.
    Rambausek M; Waldherr R; Rauterberg W; Andrassy K; Ritz E
    Nephron; 1987; 47(3):190-3. PubMed ID: 3683687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenetic aspects and gene polymorphisms of IgA nephropathy.
    Maixnerová D; Merta M; Reiterová J; Stekrová J; Rysavá R; Obeidová H; Tesar V
    Prague Med Rep; 2006; 107(2):171-88. PubMed ID: 17066738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy.
    van der Boog PJ; van Kooten C; van Seggelen A; Mallat M; Klar-Mohamad N; de Fijter JW; Daha MR
    Nephrol Dial Transplant; 2004 Oct; 19(10):2487-93. PubMed ID: 15252166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear IgA disease of childhood developing IgA nephropathy.
    Rositto AE; Cobeñas C; Drut R
    Pediatr Dermatol; 2008; 25(3):339-40. PubMed ID: 18577038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress in IgA nephropathy.
    Coppo R; Camilla R; Amore A; Peruzzi L
    Nephron Clin Pract; 2010; 116(3):c196-8, discussion c199. PubMed ID: 20606479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical course of primary glomerulonephritis with mesangial deposits of IgA].
    Pastore A; Montinaro V; Ladisa N; Schena FP
    Ann Ital Med Int; 1987; 2(3):201-7. PubMed ID: 3275283
    [No Abstract]   [Full Text] [Related]  

  • 18. [IgA nephropathy (Berger's disease)].
    Romoşan I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(1):19-29. PubMed ID: 2861634
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrent mesangial IgA nephritis following renal transplantation.
    Odum J; Peh CA; Clarkson AR; Bannister KM; Seymour AE; Gillis D; Thomas AC; Mathew TH; Woodroffe AJ
    Nephrol Dial Transplant; 1994; 9(3):309-12. PubMed ID: 8052439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphometric comparison of the density of the mesangial deposits in idiopathic IgA-nephropathy and Schoenlein-Henoch nephritis. An ultrastructural study.
    Danilewicz M; Wagrowska-Danilewicz M
    Rocz Akad Med Bialymst; 1997; 42 Suppl 2():7-11. PubMed ID: 9646676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.